Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adult Depression
100%
Second-generation Antipsychotics
100%
Antipsychotic Augmentation
45%
Elderly Adults
18%
Antidepressant Augmentation
18%
Inception Cohort
18%
Mortality Risk
18%
Active Comparator
18%
Treatment-resistant Depression
18%
Inferential Analysis
18%
Observational Research
9%
Augmentation Treatment
9%
Medicaid
9%
Epidemiology
9%
Clinical Care
9%
Major Depressive Disorder
9%
Fast-growing
9%
Cohort Design
9%
Acute Myocardial Infarction
9%
Dementia
9%
Age Groups
9%
Remission
9%
Heterogeneous Treatment Effects
9%
Clinical Population
9%
Pharmacological Treatment
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Pneumonia
9%
Geographic Characteristics
9%
Treatment Step
9%
Health Policy
9%
Treatment Alternatives
9%
Propensity Score Methods
9%
Demographic Characteristics
9%
Serious Adverse Events
9%
Residual Confounding
9%
Quantitative Sensitivity Analysis
9%
Antidepressant Monotherapy
9%
Depressive Symptoms
9%
Antidepressant Treatment
9%
Outpatient Visits
9%
Clinical Characteristics
9%
Instrumental Analysis
9%
New Episode
9%
Lack of Response
9%
Adverse Effects
9%
All-cause Mortality
9%
Healthcare Challenges
9%
Sequential Treatment
9%
Depressed Patients
9%
Incomplete Response
9%
Policy Efforts
9%
Cardiovascular Risk
9%
Comparator Group
9%
Stroke Subtypes
9%
Augmentation Strategy
9%
Venous Thromboembolism
9%
Elderly Dementia Patient
9%
By Design
9%
Sudden Cardiac Death
9%
Randomized Clinical Trial
9%
Class Level
9%
Personalized Treatment
9%
Safety Study
9%
Medicine and Dentistry
Antidepressant
100%
Treatment Resistant Depression
50%
Health Care
50%
Adverse Event
25%
Major Depressive Episode
25%
Sudden Cardiac Death
25%
All Cause Mortality
25%
Instrumental Variable Analysis
25%
Venous Thromboembolism
25%
Treatment Effect
25%
Outpatient
25%
Depression of Adult
25%
Monotherapy
25%
Acute Heart Infarction
25%
Cohort Effect
25%
Maturity Onset Diabetes of the Young
25%
Clinical Population
25%
Randomized Clinical Trial
25%
Drug Therapy
25%
Apoplexy
25%
Cardiovascular Risk
25%
Depressive Disorder
25%
Adverse Effect
25%
Population Research
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Treatment Resistant Depression
50%
Adverse Event
25%
Monotherapy
25%
Randomized Clinical Trial
25%
Cardiovascular Risk
25%
Venous Thromboembolism
25%
Acute Heart Infarction
25%
Major Depression
25%
Remission
25%
Sudden Cardiac Death
25%
All Cause Mortality
25%
Non Insulin Dependent Diabetes Mellitus
25%
Cerebrovascular Accident
25%
Depressive Disorder
25%
Population Study
16%